Skip to content
TrialScanner

NCT02025621

Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass

Phase 3CompletedTENXLead

Registry record

Lead sponsor
Tenax Therapeutics, Inc.
Conditions
Coronary Artery Bypass Grafting; Mitral Valve Surgery; Low Cardiac Output Syndrome
Primary completion
Nov 2016Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02025621 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02025621: Levosimendan in Patients... | TrialScanner